Post-earnings recap
Reported
Sun, Aug 9, 2026
EPS actual
$0.29
EPS est.
$0.21
EPS surprise
+38.10%
1-day move
+6.20%
RadNet's earnings report shows a strong performance in EPS, exceeding expectations significantly. The positive surprise likely contributed to the stock's 6.2% increase in value. However, without revenue figures and management commentary, investors may have limited insight into the company's overall performance and future outlook.
| Metric | Actual | Expected | Surprise |
|---|---|---|---|
| EPS | $0.29 | $0.20 | +38.10% |
| Revenue | — | $609M | — |
No transcript is on record for the earnings call, so the analysis is based solely on numerical results.
RadNet, Inc. is a leading provider of imaging services in the healthcare sector, specializing in advanced radiology and diagnostic imaging. With a market cap of $6 billion, the company plays a crucial role in the growing demand for healthcare services, particularly as the population ages and requires more medical imaging.
Last quarter
In Q1-2026, RadNet reported an EPS of -$0.28, missing expectations significantly. The stock reacted positively the next day, gaining 1.20%, despite the disappointing earnings.
EPS beat streak
1Q
EPS beat rate
63%
Avg EPS surprise
-2.88%
Avg 1-day reaction
+1.69%
Analysts are cautiously optimistic, expecting RadNet to report an EPS of $0.20 and revenue of $609 million for Q2-2026. However, the company's recent earnings history shows volatility and mixed results.
Bull case
If RadNet can exceed the EPS estimate, it may signal improved operational efficiency and patient volume, potentially leading to a strong stock performance.
Bear case
Conversely, if the company misses earnings expectations again, it could raise concerns about its growth trajectory and operational challenges, leading to a negative market reaction.
Key metrics to watch
EPS
$0.20Earnings per share is a key indicator of profitability and will show how well the company is managing costs and generating income.
Revenue
$609MTotal revenue reflects the company's ability to attract and retain patients, which is vital for growth in the competitive healthcare market.
The print will turn on these.
Q1
Will RadNet achieve an EPS of at least $0.20?
This figure is critical as it reflects the company's profitability and operational efficiency, which investors will closely scrutinize.
Q2
How has patient volume changed compared to previous quarters?
Understanding patient volume trends will provide insight into the company's growth potential and market demand for its services.
—
Est. EPS
$0.56
Est. Rev
$1.3B
Impl. Move
±8.8%
Why consensus could be wrong
The Street may underestimate RadNet's ability to recover from previous earnings misses, as recent operational changes could lead to improved patient volumes and profitability.
Supporting evidence
The options market is pricing in a larger move than historical averages, suggesting heightened expectations.
RadNet's recent investments in technology and service expansion may not be fully reflected in analyst estimates.
Key risk
If patient volume increases significantly, it could lead to a much higher EPS than the consensus estimate.
Pre-commit to what would confirm each case.
This quarter's performance is critical as it follows a significant earnings miss, and the market will be watching closely for signs of recovery.
Bull confirmed if
An EPS of $0.25 or higher would confirm the bull case, indicating strong operational performance.
Bear confirmed if
An EPS below $0.16 would validate the bear case, raising concerns about the company's ability to generate profits.
What the market is pricing for the move.
Implied Move
±12.72%
Historical Avg
±2.9%
The options market is pricing in a significant move, indicating that traders expect volatility around the earnings announcement.
Options are pricing ±12.7% while RDNT has averaged ±2.9% over the last 8 prints — setup is pricing rich.
ATM IV
0.6%
30d HV
33.7%
Cross-company pattern from 30 similar setups.
Prior-quarter miss + options pricing rich setup in Health Care
Fade rate: 13 of 29 (45%)
This setup has occurred 30 times across Health Care in the last 2 years. 13 of 29 faded and 16 held — no strong directional bias after the initial reaction. The average absolute 1-day move is 3.6%, with a raw directional average of -1.3% (modestly negative historical bias).
Smart-money positioning from the most recent 13F filings.
Institutional
105.40%
of float
Insider
9.96%
of float
Holders
447
institutions
Top Holders· as of Jun 2026
Blackrock Inc.
10,957,808 sh · $751.8M
13.92%
9.2%
Likely market behavior by outcome. Not investment advice.
Beat & raise
If RadNet beats expectations, history suggests the stock could rise by around 2.00%, confirming a positive outlook for the company.
In line / cautious
If results are in line with expectations, the stock may see a muted reaction as investors await further guidance.
Miss
A miss on earnings could lead to a decline of approximately 1.25%, reflecting ongoing concerns about the company's performance.
The lines on the call that would change the story.
RTW Investments LP
4,846,958 sh · $332.5M
6.16%
13.1%
Price (T.Rowe) Associates Inc
4,501,195 sh · $308.8M
5.72%
8.3%
Vanguard Portfolio Management LLC
4,066,931 sh · $279.0M
5.17%
4.3%
Vanguard Capital Management LLC
3,193,565 sh · $219.1M
4.06%
2.7%
13F filings updated quarterly. Position deltas show change in shares vs. the prior quarter.